Biora Therapeutics(BIOR) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain compliance with Nasdaq listing requirements for market value of securities SAN DIEGO, November 14, 2024 – Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today provided a c ...